Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Urinary Estrogen Metabolites and Prostate Cancer Risk: A Pilot Study
  2. Kosti, O.; Xu, X.; Veenstra, T. D.; Hsing, A. W.; Chu, L. W.; Goldman, L.; Bebu, I.; Collins, S.; Dritschilo, A.; Lynch, J. H.; Goldman, R.
  3. Prostate. 2011, Apr; 71(5): 507-516.
  1. 2.   The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer
  2. Diaz, R.; Nguewa, P. A.; Diaz-Gonzalez, J. A.; Hamel, E.; Gonzalez-Moreno, O.; Catena, R.; Serrano, D.; Redrado, M.; Sherris, D.; Calvo, A.
  3. British Journal of Cancer. 2009 100(6): 932-940.
  1. 3.   A Liquid Chromatography-Mass Spectrometry Method for the Simultaneous Measurement of 15 Urinary Estrogens and Estrogen Metabolites: Assay Reproducibility and Interindividual Variability
  2. Falk, R. T.; Xu, X.; Keefer, L.; Veenstra, T. D.; Ziegler, R. G.
  3. Cancer Epidemiology Biomarkers & Prevention. 2008 17(12): 3411-3418.
  1. 4.   Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198
  2. LaVallee, T. M.; Burke, P. A.; Swartz, G. M.; Hamel, E.; Agoston, G. E.; Shah, J.; Suwandi, L.; Hanson, A. D.; Fogler, W. E.; Sidor, C. F.; Treston, A. M.
  3. Molecular Cancer Therapeutics. 2008 7(6): 1472-1482.
  1. 5.   Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines
  2. Hurt, E. M.; Thomas, S. B.; Peng, B.; Farrar, W. L.
  3. British Journal of Cancer. 2007, Oct; 97(8): 1116-1123.
  1. 6.   Pharmacokinetics, pharmacodynamics and drug metabolism - Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol
  2. Lakhani, N. J.; Sparreboom, A.; Xu, X.; Veenstra, T. D.; Venitz, J.; Dahut, W. L.; Figg, W. D.
  3. Journal of Pharmaceutical Sciences. 2007, Jul; 96(7): 1821-1831.
  1. 7.   Integrated molecular profiling of SOD2 expression in multiple myeloma
  2. Hurt, E. M.; Thomas, S. B.; Peng, B. J.; Farrar, W. L.
  3. Blood. 2007, May; 109(9): 3953-3962.
  1. 8.   Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry
  2. Xu, X.; Roman, J. M.; Veenstra, T. D.; Van Anda, J.; Ziegler, R. G.; Issaq, H. J.
  3. Analytical Chemistry. 2006, MAR 1; 78(5): 1553-1558.
  1. 9.   A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach
  2. Nguyen, T. L.; McGrath, C.; Hermone, A. R.; Burnett, J. C.; Zaharevitz, D. W.; Day, B. W.; Wipf, P.; Hamel, E.; Gussio, R.
  3. Journal of Medicinal Chemistry. 2005, SEP 22; 48(19): 6107-6116.
  1. 10.   Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization
  2. Edsall, A. B.; Mohanakrishnan, A. K.; Yang, D. L.; Fanwick, P. E.; Hamel, E.; Hanson, A. D.; Agoston, G. E.; Cushman, M.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5126-5139.
  1. 11.   Synthesis of B-ring homologated estradiol analogues that modulate tubulin polymerization and microtubule stability
  2. Wang, Z. Q.; Yang, D. L.; Mohanakrishnan, A. K.; Fanwick, P. E.; Nampoothiri, P.; Hamel, E.; Cushman, M.
  3. Journal of Medicinal Chemistry. 2000 43(12): 2419-2429.
  1. 12.   A steroid derivative with paclitaxel-like effects on tubulin polymerization
  2. Verdier-Pinard, P.; Wang, Z. Q.; Mohanakrishnan, A. K.; Cushman, M.; Hamel, E.
  3. Molecular Pharmacology. 2000 57(3): 568-575.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel